Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 997 results for "first pharma"

India to get animal resource facility

In a major boost for Pharma industry, scientists and medical universities, India is all set to have its first ever National Animal Resource facility for biomedical research which will have animals of defined quality that will help obtain reliable results for ... Asian Age, 6 days ago

84 images for first pharma

ETurboNews, 4 days ago
Pharma Letter, 1 week ago
West Australian, 1 week ago
Business Standard, 1 day ago
Business Standard India, 1 hour ago
Business Standard India, 5 hours ago
Livemint.com, 3 days ago
Business Standard India, 4 hours ago
Business Standard, 9 hours ago
Business Standard India, 12 hours ago
Livemint.com

CCI expands probe into Sun Pharma-Ranbaxy deal

W This is probably the first instance where the Competition Commission of India (CCI) has ordered a public scrutiny of a proposed merger and acquisition (M&A) deal to ensure compliance to fair trade regulations. Sun Pharma and Ranbaxy, which had ...
 Moneycontrol.com4 days ago Competition Commission extends Sun Pharma-Ranbaxy probe to new stage  Livemint.com4 days ago Sun Pharma-Ranbaxy CCI probe in new phase [Mint, New Delhi :: ]  BusinessWeek4 days ago CCI expands probe into Sun-Ranbaxy deal  Asian Age4 days ago
[x]  
EuroInvestor

EU grants orphan drug status to Innate Pharma's IPH4102 to treat cutaneous T-cell lymphoma

Innate Pharma SA, the innate immunity company developing first-in-class drug candidates for cancer and inflammatory diseases, announced that the European Commission has granted orphan drug designation to IPH4102 for the treatment of cutaneous T-cell ...
 PharmaBiz2 days ago REG-INNATE PHARMA : ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR IPH4102  Reuters5 days ago INNATE PHARMA : ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR IPH4102  Morningstar.com5 days ago Innate Pharma Orphan Drug Designation In The European Union For Iph4102  Big News Network5 days ago
[x]  
European Pharmaceutical Manufacturer

Future of pharma the focus of inaugural industry-wide live chat

CPhI Worldwide , organised by UBM Live , announced the launch of #CPhIChat in October 2014. #CPhIChat is a first of its kind global industry-wide Tweetchat for pharma professionals and media working across the supply chain, aimed to stimulate ...
 Pharmaceutical & Medical Packaging News4 days ago CPhI Worldwide to host #CPhIChat provoking debate on the future of pharma  PharmiWeb4 days ago CPhI Worldwide to Host Tweetchat #CPhIChat on Key Issues Facing the Pharma Industry  PharmTech.com4 days ago CPhI Worldwide to host Tweetchat provoking debate on the future of pharma  Manufacturing Chemist4 days ago
[x]  

Buy Ajanta Pharma; target of Rs 1758: Firstcall Research

Firstcall research report on Ajanta Pharma Ajanta Pharma - a speciality pharmaceutical formulation company has leading brands in therapeutic segments of Ophthalmology, Dermatology, Cardiology and pain management. Many of company's products are ...
 Moneycontrol.com4 days ago
Sify

NPPA grants price exemption for Torrent Pharma's FDC drug

This is the first product under the new drug pricing policy to receive exemption
 Business Standard6 days ago Torrent Pharma gets price exemption for new FDC drug  Business Standard1 week ago
[x]  
Money Today

Sun Pharma posts profit of Rs 1,390 crore in Q1

Net sales of the company rose to Rs 3,926.85 crore for the first quarter, as compared to Rs 3,482.18 crore in the same period of previous fiscal, Sun Pharma said in a statement. "Our Q1 performance was in-line with our expectations. While we are intensively ...
 Money Today2 weeks ago Cardiome Pharma Q2 net loss increases  Individual.com6 days ago Sun Pharma posts Q1 profit at Rs 1,390 cr  Money Control2 weeks ago Sun Pharma posts Q1 profit on strong US sales  The Financial Chronicle2 weeks ago

Venus gets mkt authorisation from Swiss drug authority

Pharma major Venus Remedies has secured its first marketing authorisation in Switzerland from Swiss drug authority 'Swissmedic' for its oncology drug 'Gemcitabine'. The marketing approval for Gemcitabine will help the company further strengthen its ...
 Business Standard1 week ago Venus Remedies gets first marketing authorisation in Switzerland for Gemcitabine  Money Control1 week ago Venus gets market authorisation from Swiss drug authority  The Financial Chronicle1 week ago Venus Remedies soars 10% on Swiss nod for anti-cancer drug  Money Control1 week ago

Dishman Pharma Q1 net dips 19% at Rs 23.81 cr

d 18.59 per cent dip in consolidated net profit at Rs 23.81 crore for the first quarter ended June 30, 2014-15. It had posted net profit of Rs 29.25 crore for the April- June quarter of 2013-14, Dishman in a filing to the BSE. Consolidated net sales of the ...
 Business Standard2 weeks ago Natco Pharma Q1 increases 53.62 per cent at Rs 33.46 crore  Business Standard2 weeks ago Aurobindo Pharma posts net profit of Rs 393.40 cr in Q1  Business Standard3 weeks ago

Sun Pharma net up

Industries Ltd posted a net profit of Rs.1,391 crore (adjusted) for first quarter of fiscal 2014-15, registering 12 percent year-on-year (YoY) growth. According to the company's release Wednesday, net sales for the quarter grew 13 percent YoY to Rs.3,927 ...
 Business Standard2 weeks ago Alembic Q1 net up 24%  Business Line1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less